Maya Belhadj Selected Research

1- ((2- ((2- chloropyridin- 4yl)amino)- 4'- (cyclopropylmethyl)- (4,5'- bipyrimidin)- 2'- yl)amino)- 2- methylpropan- 2- ol

10/2020

Antileukemic activity of the VPS34-IN1 inhibitor in acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maya Belhadj Research Topics

Disease

1	Neoplasms (Cancer) 11/2021
1	Myeloid Sarcoma (Chloroma) 11/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020

Drug/Important Bio-Agent (IBA)

1	nelarabine (506U78)FDA Link 11/2021
1	venetoclaxIBA 11/2021
1	1- ((2- ((2- chloropyridin- 4yl)amino)- 4'- (cyclopropylmethyl)- (4,5'- bipyrimidin)- 2'- yl)amino)- 2- methylpropan- 2- olIBA 10/2020

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 11/2021